Shelf life (days): 1460.0
Formulation: A crystalline solid
Formal Name: 3-[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-benzeneacetonitrile
Purity: ≥98%
Formula Markup: C26H26FN7
Formula Weight: 455.5
CAS Number: 1239875-86-5
Notes: SGI-7079 is an inhibitor of the receptor tyrosine kinase Axl.{38140} It inhibits proliferation of inflammatory breast cancer cells (IC50s = 0.43 and 0.15 µM for SUM149 and KPL-4 cells, respectively), decreases invasion, and halts the cell cycle in the G1 phase. SGI-7079 synergistically increases the potency of erlotinib (Item No. 10483) on EGFR inhibition.{38139} In a mouse xenograft model of non-small cell lung cancer, SGI-7079 dose-dependently inhibits tumor growth, an effect that is greater when used in combination with erlotinib.